Table of Contents Author Guidelines Submit a Manuscript
Journal of Nanomaterials
Volume 2011, Article ID 851520, 5 pages
http://dx.doi.org/10.1155/2011/851520
Research Article

Magnetically Directed Targeting Aggregation of Radiolabelled Ferrite Nanoparticles

1Department of Nuclear Medicine, Buddhist Dalin Tzu Chi General Hospital, Chiayi 62247, Taiwan
2School of Medicine, Tzu Chi University, Hualien 97004, Taiwan
3School of Pharmacy, Kaohsiung Medical University, Kaohsiung 80708, Taiwan
4Department of Physics, National Taiwan University, Taipei 10617, Taiwan
5Department of Pharmacy, Buddhist Dalin Tzu Chi General Hospital, Chiayi 62247, Taiwan

Received 12 August 2010; Accepted 10 April 2011

Academic Editor: Rakesh Joshi

Copyright © 2011 Yuh-Feng Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. A. Clynes, T. L. Towers, L. G. Presta, and J. V. Ravetch, “Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets,” Nature Medicine, vol. 6, no. 4, pp. 443–446, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. C. A. Reade and A. K. Ganti, “EGFR targeted therapy in non-small cell lung cancer: potential role of cetuximab,” Biologics, vol. 3, pp. 215–224, 2009. View at Google Scholar
  3. M. D. Pescovitz, C. J. Greenbaum, H. Krause-Steinrauf et al., “Rituximab, B-lymphocyte depletion, and preservation of beta-cell function,” New England Journal of Medicine, vol. 361, no. 22, pp. 2143–2152, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. B. Li, L. Zhao, H. Guo et al., “Characterization of a rituximab variant with potent antitumor activity against rituximab-resistant B-cell lymphoma,” Blood, vol. 114, no. 24, pp. 5007–5015, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. M. F. Giblin, G. L. Sieckman, T. D. Shelton, T. J. Hoffman, L. R. Forte, and W. A. Volkert, “In vitro and in vivo evaluation of 177Lu- and 90Y-labeled E. coli heat-stable enterotoxin for specific targeting of uroguanylin receptors on human colon cancers,” Nuclear Medicine and Biology, vol. 33, no. 4, pp. 481–488, 2006. View at Publisher · View at Google Scholar · View at PubMed
  6. Z. Shen, W. Wei, Y. Zhao et al., “Thermosensitive polymer-conjugated albumin nanospheres as thermal targeting anti-cancer drug carrier,” European Journal of Pharmaceutical Sciences, vol. 35, no. 4, pp. 271–282, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. J. E. Cyr, D. A. Pearson, D. M. Wilson et al., “Somatostatin receptor-binding peptides suitable for tumor radiotherapy with Re-188 or Re-186. Chemistry and initial biological studies,” Journal of Medicinal Chemistry, vol. 50, no. 6, pp. 1354–1364, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. D. Kopelman and M. Papa, “Magnetic resonance-guided focused ultrasound surgery for the noninvasive curative ablation of tumors and palliative treatments: a review,” Annals of Surgical Oncology, vol. 14, no. 5, pp. 1540–1550, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. B. Sangro, J. I. Bilbao, M. Iñarrairaegui, M. Rodriguez, P. Garrastachu, and A. Martinez-Cuesta, “Treatment of hepatocellular carcinoma by radioembolization using y microspheres,” Digestive Diseases, vol. 27, no. 2, pp. 164–169, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. K. T. Sato, R. J. Lewandowski, M. F. Mulcahy et al., “Unresectable chemorefractory liver metastases: radioembolization with Y microspheres—safety, efficacy, and survival,” Radiology, vol. 247, no. 2, pp. 507–515, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. C. M. Fu, Y. F. Wang, Y. C. Chao, S. H. Hung, and M. D. Yang, “Directly labeling ferrite nanoparticles with Tc-99m radioisotope for diagnostic applications,” IEEE Transactions on Magnetics, vol. 40, no. 4, pp. 3003–3005, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. C. M. Fu, Y. F. Wang, Y. F. Guo, T. Y. Lin, and J. S. Chiu, “In vivo bio-distribution of intravenously injected Tc-99 m labeled ferrite nanoparticles bounded with biocompatible medicals,” IEEE Transactions on Magnetics, vol. 41, no. 10, pp. 4120–4122, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. AI. Y. Wang, C. L. Kuo, J. L. Lin, C. M. Fu, and Y. F. Wang, “Study of magnetic ferrite nanoparticles labeled with Tc- pertechnetate,” Journal of Radioanalytical and Nuclear Chemistry, vol. 284, no. 2, pp. 405–413, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Philipp, M. Meyer, and E. Wagner, “Extracellular targeting of synthetic therapeutic nucleic acid formulations,” Current Gene Therapy, vol. 8, no. 5, pp. 324–334, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. V. Hofmeister, D. Schrama, and J. C. Becker, “Anti-cancer therapies targeting the tumor stroma,” Cancer Immunology, Immunotherapy, vol. 57, no. 1, pp. 1–17, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. K. Manjunath, J. S. Ready, and V. Venkateswarlu, “Solid lipid nanoparticles as drug delivery systems,” Methods and Findings in Experimental and Clinical Pharmacology, vol. 27, no. 2, pp. 127–144, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. K. Cho, X. Wang, S. Nie, Z. Chen, and D. M. Shin, “Therapeutic nanoparticles for drug delivery in cancer,” Clinical Cancer Research, vol. 14, no. 5, pp. 1310–1316, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus